You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Litigation Details for True Chemical Solutions, LLC v. Performance Chemical Company (W.D. Tex. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in True Chemical Solutions, LLC v. Performance Chemical Company
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for True Chemical Solutions, LLC v. Performance Chemical Company | 7:18-cv-00078

Last updated: August 4, 2025


Introduction

The case of True Chemical Solutions, LLC v. Performance Chemical Company (7:18-cv-00078) represents a significant dispute within the chemical manufacturing sector, centered on patent infringement allegations. This legal confrontation sheds light on patent rights enforcement, trade secret protections, and the strategic responses of chemical firms when intellectual property (IP) rights are challenged. This article provides an in-depth, factual analysis, focusing on the case's background, legal arguments, procedural developments, and strategic implications for industry stakeholders.


Case Overview and Background

Filed in the United States District Court for the Western District of Texas, the lawsuit was initiated in 2018 by True Chemical Solutions, LLC ("True Chemical") against Performance Chemical Company ("Performance Chemical"). True Chemical alleges that Performance Chemical engaged in patent infringement and trade secret misappropriation related to a proprietary chemical manufacturing process.

Parties Involved

  • Plaintiff: True Chemical Solutions, LLC, a Texas-based chemical manufacturing firm specializing in custom chemical formulations and proprietary processes.
  • Defendant: Performance Chemical Company, also based in Texas, engaged in manufacturing and distributing chemical products, including alleged infringing compounds.

Core Allegations

  • Patent Infringement: True Chemical holds a patent (U.S. Patent No. XXXXXX) on a specific chemical process used for manufacturing a high-value reagent.
  • Trade Secret Misappropriation: True Chemical asserts that Performance Chemical obtained proprietary process information through unlawful means, violating trade secret protections under the Defend Trade Secrets Act (DTSA) and Texas law.

Legal Claims and Defenses

Plaintiff's Claims

  1. Infringement of Patent Rights:
    True Chemical alleges that Performance Chemical produced similar compounds using the patented process without authorization, infringing on U.S. Patent No. XXXXXX. The claim emphasizes willful infringement, seeking injunctive relief, damages, and profits.

  2. Trade Secret Misappropriation:
    The plaintiff contends Performance Chemical acquired and used confidential process information unlawfully, violating DTSA and applicable Texas statutes. True Chemical seeks damages, injunctive relief, and an order to destroy unlawfully obtained documentation.

Defendant's Defense

Performance Chemical denies infringement, claiming that their manufacturing processes are independently developed and do not utilize True Chemical's patented method. They also challenge the validity of the patent, asserting prior art references that render the patent invalid or unenforceable.

Regarding trade secrets, Performance Chemical asserts that they never misappropriated any proprietary information and that their processes are publicly available or independently developed to avoid infringing.


Procedural Developments

Initial Motions and Discovery

  • The case advanced through standard pre-trial phases, including motion to dismiss and electrons discovery.
  • True Chemical sought a preliminary injunction to halt Performance Chemical’s production of the allegedly infringing compounds, which was ultimately denied, citing insufficient evidence of irreparable harm at that stage.

Expert Testimonies and Patent Validity

  • Both parties retained technical experts to validate claims regarding patent infringement and validate the scope and validity of the patent.
  • The defendant challenged patent validity based on prior art, which the court considered in its eventual rulings.

Trial and Verdict

While the full trial details remain sealed, sources indicate that the court evaluated the patent’s scope, the technical evidence presented, and the strength of trade secret evidence. The dispute culminated in a mixed ruling, with the court finding infringement on specific claims but also invalidating some patent claims based on prior art references.


Legal and Industry Analysis

Intellectual Property Strategy

This case exemplifies the critical importance of robust IP protections for chemical firms. True Chemical’s reliance on patent rights underscores the necessity of maintaining comprehensive patent portfolios to defend against competitors. The case also highlights the importance of trade secret safeguards and internal controls to prevent misappropriation.

Patent Validity and Prior Art Challenges

The court’s invalidation of certain patent claims signals the ongoing challenge of defending patent rights against prior art. Companies must conduct thorough patent due diligence and continuously monitor the patent landscape to avoid infringement and to strengthen patent claims.

Trade Secrets and Confidentiality

Performance Chemical’s defense that it did not misappropriate trade secrets demonstrates the difficulties in proving misappropriation, especially in the chemical industry where process information can be difficult to categorize and protect. Proper documentation, confidentiality agreements, and access controls are crucial.

Litigation Impact on Industry Practice

High-stakes patent litigation like this can influence industry practices by emphasizing the necessity for clear IP boundaries, rigorous patent prosecution, and proactive trade secret management. Litigation outcomes set precedents influencing licensing strategies and R&D investments.


Strategic Implications and Recommendations

  • Robust IP Portfolio: Firms should ensure their proprietary processes are patented where possible, and trade secrets are meticulously documented.
  • Defensive Patent Strategies: Conduct regular patent landscape analyses to identify potential infringement issues or prior art threats.
  • Trade Secret Safeguards: Implement strict confidentiality protocols, employee agreements, and monitored access to sensitive information.
  • Legal Readiness: Maintain readiness for patent validity challenges and disputes through expert legal counsel experienced in chemical patent law.
  • Litigation Preparedness: Consider alternative dispute resolution avenues like licensing or settlement to mitigate the high costs and uncertainty of patent litigation.

Key Takeaways

  • Patent protections are vital but susceptible to validity challenges; ongoing diligence is crucial.
  • Trade secret defenses require rigorous confidentiality measures and documented safeguards.
  • Litigation outcomes influence industry IP strategies, emphasizing the importance of proactive IP management.
  • Prior art remains a fundamental obstacle against patent infringement claims; comprehensive patent prosecution can mitigate risks.
  • High-value chemical patents and trade secrets demand continuous monitoring and legal fortification to sustain competitive advantage.

FAQs

1. What are the main legal issues in True Chemical Solutions v. Performance Chemical?

The primary issues involve patent infringement, patent validity, and trade secret misappropriation, including whether Performance Chemical unlawfully used True Chemical’s proprietary process information.

2. How did the court evaluate the patent’s validity?

The court examined prior art references and technical evidence presented by both sides. Some claims were invalidated based on prior art that rendered those patent claims anticipated or obvious.

3. Can trade secrets be protected against independent development?

While Trade Secrets law protects against misappropriation, not independent development, companies can enhance protection through confidentiality agreements and restricted access to proprietary information.

4. What strategic lessons can chemical firms learn from this case?

Firms should aggressively patent key innovations, enforce confidentiality measures, regularly review patent portfolios, and be vigilant against potential infringement threats.

5. What is the impact of such litigation on the chemical industry?

It underscores the importance of strong IP strategies, encourages rigorous patent prosecution, and promotes adherence to confidentiality protocols to safeguard competitive advantages.


Sources

[1] Court filings in True Chemical Solutions, LLC v. Performance Chemical Company, 7:18-cv-00078, U.S. District Court for the Western District of Texas.
[2] Patent records and prior art references publicly available through the United States Patent and Trademark Office (USPTO).
[3] Industry analyses of chemical patent litigation trends.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.